Melola Discovery

← Melola Discovery

Akses terbuka Jurnal SINTA 1

Elephantopus scaber Linn. Leaf Extract Sensitizes Doxorubicin in Inducing Apoptosis in HSC-3 Tongue Cancer Cells through Inhibiting Survivin Activity at Thr34

The Indonesian Biomedical Journal · Vol. 16 No. 4 (2024) · hlm. 372–378

DOI
10.18585/inabj.v16i4.3096
ISSN
2085-3297, 2355-9179
Terbit
2024-08-28
Penerbit
Secretariat of The Indonesian Biomedical Journal
Bahasa
en
Lisensi
creativecommons.org/licenses/by-nc/4.0/

Abstrak

BACKGROUND: Previous research has demonstrated the effect of Elephantopus scaber Linn. leaf extract (ESLE) on various cancer cell lines. However, research on the effects of ESLE on oral squamous cell carcinoma (OSCC), especially tongue cancer, is still lacking. Moreover, the apoptotic mechanisms induced by ESLE are not well understood and require further exploration. Therefore, this study was conducted to investigate the effects of ESLE on cell viability and apoptosis in human squamous cell carcinoma (HSC)-3 tongue cancer cells.METHODS: HSC-3 cells were treated with varying concentrations of ESLE, doxorubicin, and a combination of both. Cell viability and apoptosis were assessed using MTT and Sub-G1 assays. The expression levels of survivin and its phosphorylated form at threonine (Thr)34 were evaluated using Western blot analysis.RESULTS: ESLE exhibited a concentration-dependent cytotoxic effect on HSC-3 cells in decreasing cell viability (Kruskal Wallis, p=0.001) and increasing apoptotic cells (ANOVA, p=0.001) significantly. When combined with doxorubicin, ESLE further enhanced the induction of apoptosis compared with doxorubicin alone. The combined treatment resulted in a decrease in the levels of phosphorylated survivin (p-Surv) Thr34, indicating the inhibition of survivin's anti-apoptotic function.CONCLUSION: ESLE significantly enhances the efficacy of doxorubicin, thereby sensitizing its ability to induce apoptosis in HSC-3 tongue cancer cells. This sensitization occurs through the inhibition of survivin activity, particularly at the Thr34 phosphorylation site. These findings suggest that ESLE could serve as a potential adjuvant to improve the effectiveness of doxorubicin in inducing apoptosis in tongue cancer cells.KEYWORDS: Elephantopus scaber, doxorubicin, tongue cancer, HSC-3 cells, apoptosis, Survivin, Thr34 phosphorylation

Kata kunci

Jaringan kolaborasi para penulis

40 penulis · 99 tautan kepenulisan bersama · 54 lintas organisasi · menampilkan 40 yang paling banyak terhubung

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • Universitas Trisakti
  • University of Indonesia
  • University of Brawijaya
  • Universitas Airlangga
  • Hasanuddin University
  • PT Prodia StemCell Indonesia (Indonesia)
  • Kyushu University
  • Organisasi lain
  • Afiliasi tidak diketahui
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
Johni HalimUniversitas Trisakti9
Muhammad Ihsan RizalUniversitas Trisakti7
Melanie Sadono DjamilUniversitas Trisakti7
Nurrani Mustika DewiPadjadjaran University6
Visi Endah PratitisAfiliasi tidak diketahui5
Janti SudionoUniversitas Trisakti4
Angliana ChouwPT Prodia StemCell Indonesia (Indonesia)4
Djanggan SargowoUniversity of Brawijaya4
Wahyu WidowatiMaranatha Christian University3
Yanni DirgantaraPT Prodia StemCell Indonesia (Indonesia)3
Maria CelinnaAfiliasi tidak diketahui3
Toshio KukitaKyushu University3
Roya Khosravi‐FarBeth Israel Deaconess Medical Center3
Irawan YusufHasanuddin University3
Solachuddin Jauhari Arief IchwanUniversiti Brunei Darussalam3
Ketherin KetherinUniversitas Trisakti2
Tjandrawati MozefIndonesian Institute of Sciences2
Ardian RizalUniversity of Brawijaya2
Tadahiko IijimaKyushu University2
Sonar Soni PanigoroRumah Sakit Umum Pusat Nasional Dr. Cipto Mangunkusumo2
Herqutanto HerqutantoUniversity of Indonesia2
Andon HestiantoroRumah Sakit Umum Pusat Nasional Dr. Cipto Mangunkusumo2
Nyoman Suci WidyastitiDiponegoro University2
Pudji RahajuUniversity of Brawijaya2
Ahmad Dian WahyudionoUniversity of Brawijaya2
Reza Gunadi RanuhUniversitas Airlangga2
Alpha Fardah AthiyyahUniversitas Airlangga2
Andy DarmaUniversitas Airlangga2
Subijanto Marto SudarmoUniversitas Airlangga2
Bambang SutrisnaUniversity of Indonesia2
Mansyur ArifHasanuddin University2
Andi WijayaHasanuddin University2
Primariadewi RustamadjiUniversity of Indonesia2
Aria KekalihUniversity of Indonesia2

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OpenAlex API (jurnal SINTA, ADR 0048) https://openalex.org/S2764892910, pertama di-harvest 19 Nov 2026, terakhir terlihat 19 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"><dc:title xml:lang="en">Elephantopus scaber Linn. Leaf Extract Sensitizes Doxorubicin in Inducing Apoptosis in HSC-3 Tongue Cancer Cells through Inhibiting Survivin Activity at Thr34</dc:title><dc:creator>Ferry Sandra</dc:creator><dc:creator>Ria Aryani Hayuningtyas</dc:creator><dc:creator>Dewi Ranggaini</dc:creator><dc:creator>Tiffany Pang</dc:creator><dc:creator>Alifah Evi Scania</dc:creator><dc:creator>Kyung Hoon Lee</dc:creator><dc:subject>Elephantopus scaber</dc:subject><dc:subject>doxorubicin</dc:subject><dc:subject>tongue cancer</dc:subject><dc:subject>oral squamous cell carcinoma</dc:subject><dc:subject>HSC-3 cells</dc:subject><dc:subject>apoptosis</dc:subject><dc:subject>survivin</dc:subject><dc:subject>chemosensitization</dc:subject><dc:subject>leaf extract</dc:subject><dc:subject>cytotoxicity</dc:subject><dc:subject>combination therapy</dc:subject><dc:description xml:lang="en">BACKGROUND: Previous research has demonstrated the effect of Elephantopus scaber Linn. leaf extract (ESLE) on various cancer cell lines. However, research on the effects of ESLE on oral squamous cell carcinoma (OSCC), especially tongue cancer, is still lacking. Moreover, the apoptotic mechanisms induced by ESLE are not well understood and require further exploration. Therefore, this study was conducted to investigate the effects of ESLE on cell viability and apoptosis in human squamous cell carcinoma (HSC)-3 tongue cancer cells.METHODS: HSC-3 cells were treated with varying concentrations of ESLE, doxorubicin, and a combination of both. Cell viability and apoptosis were assessed using MTT and Sub-G1 assays. The expression levels of survivin and its phosphorylated form at threonine (Thr)34 were evaluated using Western blot analysis.RESULTS: ESLE exhibited a concentration-dependent cytotoxic effect on HSC-3 cells in decreasing cell viability (Kruskal Wallis, p=0.001) and increasing apoptotic cells (ANOVA, p=0.001) significantly. When combined with doxorubicin, ESLE further enhanced the induction of apoptosis compared with doxorubicin alone. The combined treatment resulted in a decrease in the levels of phosphorylated survivin (p-Surv) Thr34, indicating the inhibition of survivin's anti-apoptotic function.CONCLUSION: ESLE significantly enhances the efficacy of doxorubicin, thereby sensitizing its ability to induce apoptosis in HSC-3 tongue cancer cells. This sensitization occurs through the inhibition of survivin activity, particularly at the Thr34 phosphorylation site. These findings suggest that ESLE could serve as a potential adjuvant to improve the effectiveness of doxorubicin in inducing apoptosis in tongue cancer cells.KEYWORDS: Elephantopus scaber, doxorubicin, tongue cancer, HSC-3 cells, apoptosis, Survivin, Thr34 phosphorylation</dc:description><dc:publisher>Secretariat of The Indonesian Biomedical Journal</dc:publisher><dc:date>2024-08-28</dc:date><dc:type>info:eu-repo/semantics/article</dc:type><dc:format>application/pdf</dc:format><dc:identifier>https://doi.org/10.18585/inabj.v16i4.3096</dc:identifier><dc:identifier>10.18585/inabj.v16i4.3096</dc:identifier><dc:source>The Indonesian Biomedical Journal; Vol 16 No 4 (2024); 372-378</dc:source><dc:source>2085-3297</dc:source><dc:source>2355-9179</dc:source><dc:language>en</dc:language><dc:relation>https://inabj.org/index.php/ibj/article/download/3096/728</dc:relation><dc:rights>https://creativecommons.org/licenses/by-nc/4.0/</dc:rights></oai_dc:dc>